optimized CAR-strategies for clinical applications. Contact: Prof. Dr. Britta Eiz-Vesper T +49 511 532 9715 F +49 511 532 9701 Eiz-Vesper.Britta @ mh-hannover.de Cell Pharming This area of research focuses on

Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie ) & Prof. Dr. Britta Eiz-Vesper ( Transfusionsmedizin & Transplantat Engineering ) Mitglieder: Dr. Ulrike Bode ( Klinik für Allgemein-

Friederike Floegel, GERMANY, Floegel.Friederike @ mh-hannover.de Supervisor: Prof. Dr. Britta Eiz-Vesper (Transfusion Medicine) Project: Role and signature of naturally occurring endogenous and adoptively

November 2024 Philip Mausberg GERMANY Mausberg.Philip @ mh-hannover.de Supervisor: Prof. Dr. Britta Eiz-Vesper (Transfusionmedicine) Project: Gene engineered specific cells for personalized adoptive immunotherapy

Dr. Christine Falk Institute of Transfusion Medicine and Transplant Engineering Prof. Dr. Britta Eiz-Vesper Clinic for Dental Prosthetics Prof. Dr. Meike Stiesch Institute of Experimental Hematology Prof

. *equal contribution Bajor A , Tischer S, Figueiredo C, Wittmann M, Immenschuh S, Blasczyk R, Eiz-Vesper B. Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy. Clin [...] Bunse CE, Fortmeier V , Tischer S, Zilian E, Figueiredo C, Witte T, Blasczyk R, Immenschuh S, Eiz-Vesper B. Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses. Clin [...] Kaireit T , Figueiredo C, Hiller O, Maecker-Kolhoff B, Geyeregger R, Immenschuh S, Blasczyk R, Eiz-Vesper B. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer

cardiovascular disease Lea is class speaker! Juliana Peters GERMANY; Supervisor: Prof. Dr. Britta Eiz-Vesper (Transfusion Medicine) Left the program in February 2023 due to personal reasons! Anjali Shrivastava

Vandana Sharma , INDIA, sharma.vandana @ mh-hannover.de Supervisor: Prof. Dr. rer. nat. Britta Eiz-Vesper (Transfusion Medicine and Transplant Engineering) Project: Exploiting Glycosylated Tumor Antigens

sierung der SARS-CoV-2-Immunität für zelluläre Immuntherapien Projektleitung: Prof. Dr. Britta Eiz-Vesper Klinik / Institut: Institut für Transfusionsmedizin und Transplantat Engineering (ITT) In gut

clinical investigation, e163548. Advance online publication. https://doi.org/10.1172/JCI163548 Eiz-Vesper, B., Ravens, S., & Maecker-Kolhoff, B. (2023). αβ and γδ T-cell responses to Epstein-Barr Virus: [...] 1136/jitc-2022-004579. PMID: 35863820. León-Lara X, Yang T, Fichtner AS, Bruni E, von Kaisenberg C, Eiz-Vesper B, Dodoo D, Adu B, Ravens S. Evidence for an Adult-Like Type 1-Immunity Phenotype of Vδ1, Vδ2 and [...] Bak S, Tischer S, Dragon A, Ravens S, Pape L, Koenecke C, Oelke M, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its